PEER REVIEWED, EVIDENCE-BASED INFORMATION FOR CLINICIANS AND RESEARCHERS IN NEUROSCIENCE

Category: Letters to the Editor

Letter to the Editor: More Evidence is Needed Before Recommending Magic Mushrooms for the Treatment of Complicated Migraines

Innov Clin Neurosci. 2025;22(1–3):11–13. Dear Editor: I read with interest

March 1, 2025 No Comments

Letter to the Editor: Response to “More Evidence is Needed Before Recommending Magic Mushrooms for the Treatment of Complicated Migraines”

Innov Clin Neurosci. 2025;22(1–3):11–13. Dear Editor: Thank you for your

March 1, 2025 No Comments

Letter to the Editor: Sex Differences in Brain Networks Might Explain Why Female Patients with Schizophrenia Experience More Side Effects from Antipsychotic Medications

Innov Clin Neurosci. 2025;22(1–3):11–13. Dear Editor: Emerging data on sex

March 1, 2025 No Comments

Current Issue

Letter to the Editor: Schizophrenia with catatonia and stupor is an emergency and requires immediate psychiatric and neurological evaluation

Innov Clin Neurosci. 2024;21(10–12):8. Dear Editor: The interesting article by

December 1, 2024 No Comments

Letters to the Editor

Letter to the Editor: Activation of the Serotonergic Neurotransmission is a Double-edged Sword in the Treatment of Burning Mouth Syndrome

Innov Clin Neurosci. 2024;21(7–9):8–9. Dear Editor: In the treatment of

September 1, 2024 No Comments

Letters to the Editor

Letter to the Editor: Responding to commentary: addressing points raised in the correspondence about “ChatGPT and Transcranial Direct Current Stimulation for Chronic Pain”

Innov Clin Neurosci. 2024;21(4–6):8–10. Funding/financial disclosures. The authors have no

June 1, 2024 No Comments

Letters to the Editor

Letter to the Editor: Response to “ChatGPT and Transcranial Direct Current Stimulation for Chronic Pain”

Innov Clin Neurosci. 2024;21(4–6):8–10. Funding/financial disclosures. The authors have no

June 1, 2024 No Comments

Letters to the Editor

Letter to the Editor: Responding to correspondence on “Clinical Outcome Assessment Instruments in Schizophrenia: A Scoping Literature Review with a Focus on the Potential of Patient-reported Outcomes”

Innov Clin Neurosci. 2024;21(4–6):8–10. Funding/financial disclosures. Dr. Citrome is a

June 1, 2024 No Comments

Letters to the Editor

Letter to the Editor: Response to “Clinical Outcome Assessment Instruments in Schizophrenia: A Scoping Literature Review with a Focus on the Potential of Patient-reported Outcomes”

Innov Clin Neurosci. 2024;21(4–6):8–10. Funding/financial disclosures. Dr. Zaragoza Domingo is

June 1, 2024 No Comments

Letters to the Editor

Letter to the Editor: The Catastrophic Perception of Pain in Burning Mouth Syndrome May be Associated with Sympathetic Tone as Indicated by the QTc Interval

Innov Clin Neurosci. 2024;21(1–3):8–9. Funding/financial disclosures. The authors have no

March 1, 2024 No Comments

LATEST DIGITAL EDITION

ARCHIVES

Innovations in Clinical Neuroscience is a subsidiary of Matrix Medical Communications

contact

Links

About

Topics

© 2025 Matrix Medical Communications copyright all rights reserved.